NSCLC STAGE II
Clinical trials for NSCLC STAGE II explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE II trials appear
Sign up with your email to follow new studies for NSCLC STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy before lung cancer surgery shows promise in early trial
Disease control Recruiting nowThis study is for people with stage II or III non-small cell lung cancer that can be removed with surgery. Before surgery, participants will receive a combination of two immunotherapy drugs (sintilimab and IBI310) plus chemotherapy. The goal is to see if this treatment shrinks th…
Matched conditions: NSCLC STAGE II
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New combo aims to shield scarred lungs during cancer radiation
Disease control Recruiting nowThis study tests whether adding the drug BIO 300 to standard chest radiation can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease (lung scarring). About 25 participants will receive both t…
Matched conditions: NSCLC STAGE II
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Tailored workouts for lung cancer: a new pilot study
Symptom relief Recruiting nowThis study tests whether a custom exercise program, delivered via telehealth, is practical for people with stage II or III lung cancer who are getting chemotherapy, immunotherapy, or surgery. Researchers will track how many patients join and stick with the program, and monitor sa…
Matched conditions: NSCLC STAGE II
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 20, 2026 11:56 UTC